CL2019001623A1 - Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor. - Google Patents

Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor.

Info

Publication number
CL2019001623A1
CL2019001623A1 CL2019001623A CL2019001623A CL2019001623A1 CL 2019001623 A1 CL2019001623 A1 CL 2019001623A1 CL 2019001623 A CL2019001623 A CL 2019001623A CL 2019001623 A CL2019001623 A CL 2019001623A CL 2019001623 A1 CL2019001623 A1 CL 2019001623A1
Authority
CL
Chile
Prior art keywords
prevent
relieve
carbamate compound
tremor syndrome
treat
Prior art date
Application number
CL2019001623A
Other languages
English (en)
Inventor
Jin Uk Yoo
Hye Sung Lee
Han Ju Yi
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of CL2019001623A1 publication Critical patent/CL2019001623A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA A UN USO DE UNA COMPOSICIÓN FARMACÉUTICA QUE INCLUYE UN COMPUESTO DE CARBAMATO DE LA FÓRMULA QUÍMICA 1 Y SE ADMINISTRA PARA PREVENIR, ALIVIAR O TRATAR TEMBLORES O EL SÍNDROME DE TEMBLOR.
CL2019001623A 2016-12-14 2019-06-12 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor. CL2019001623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160170225 2016-12-14

Publications (1)

Publication Number Publication Date
CL2019001623A1 true CL2019001623A1 (es) 2019-08-23

Family

ID=62558966

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001623A CL2019001623A1 (es) 2016-12-14 2019-06-12 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor.

Country Status (13)

Country Link
US (1) US11033531B2 (es)
EP (1) EP3556364A4 (es)
JP (1) JP7086076B2 (es)
KR (1) KR102635941B1 (es)
CN (1) CN110267657B (es)
AU (1) AU2017374459B2 (es)
BR (1) BR112019012000A2 (es)
CA (1) CA3046300A1 (es)
CL (1) CL2019001623A1 (es)
IL (1) IL267191B2 (es)
MX (1) MX2019006941A (es)
WO (1) WO2018111009A1 (es)
ZA (1) ZA201903749B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711760B1 (en) * 2017-11-14 2024-02-14 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
CN113015524A (zh) * 2018-09-21 2021-06-22 爱思开生物制药株式会社 氨基甲酸酯化合物和包含其的制剂在预防、缓解或治疗急性应激障碍或创伤后应激障碍中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291454T3 (es) * 2001-02-27 2008-03-01 Ortho-Mcneil Pharmaceutical, Inc. Utilizacion de carbamatos para prevenir o tratar trastornos del movimiento.
EP1732564A1 (en) * 2004-03-29 2006-12-20 Merck & Co., Inc. Biaryl substituted pyrazinones as sodium channel blockers
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
KR101145395B1 (ko) * 2007-03-05 2012-07-10 인두스 바이오텍 프라이빗 리미티드 트리고넬린 및 4-하이드록시이소류신을 포함하는 약제학적 조성물 및 그 제조방법
RU2508290C2 (ru) 2009-06-22 2014-02-27 ЭсКей БАЙОФАРМАСЬЮТИКАЛЗ КО., ЛТД. Способ получения (r)-1-арил-2-тетразолилэтилового эфира карбаминовой кислоты
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CN105228604A (zh) 2013-03-12 2016-01-06 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Also Published As

Publication number Publication date
JP2020502137A (ja) 2020-01-23
EP3556364A1 (en) 2019-10-23
RU2019121914A (ru) 2021-01-15
ZA201903749B (en) 2022-01-26
IL267191A (es) 2019-07-31
IL267191B1 (en) 2023-01-01
CN110267657B (zh) 2022-12-13
US11033531B2 (en) 2021-06-15
AU2017374459B2 (en) 2023-04-27
IL267191B2 (en) 2023-05-01
KR102635941B1 (ko) 2024-02-13
WO2018111009A1 (ko) 2018-06-21
CN110267657A (zh) 2019-09-20
KR20190087573A (ko) 2019-07-24
US20190336481A1 (en) 2019-11-07
BR112019012000A2 (pt) 2019-10-29
CA3046300A1 (en) 2018-06-21
AU2017374459A1 (en) 2019-07-04
EP3556364A4 (en) 2020-06-17
MX2019006941A (es) 2019-09-06
RU2019121914A3 (es) 2021-04-21
JP7086076B2 (ja) 2022-06-17

Similar Documents

Publication Publication Date Title
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
DOP2019000117A (es) Nuevos derivados de quinolina
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
CO2017001994A2 (es) Compuestos activos hacia bromodominios
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
UY37789A (es) Nuevos derivados de azaquinolina
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
SA518400356B1 (ar) مثبطات الأرجيناز واستخداماتها العلاجية
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
MY192703A (en) Compositions containing tucaresol or its analogs
DOP2021000017A (es) Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar cánceres que incluyen los mismos
AR102973A1 (es) Uso del compuesto 3,5-dihidroxi-4-isopropil-trans-estilbeno para la preparación de una composición farmacéutica, dicho compuesto y composición farmacéutica que lo comprende
BR112018072539A2 (pt) composições de epinefrina de administração aumentada
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
BR112018014794A2 (pt) pirimidinas substituídas com arila para uso em infecção pelo vírus influenza
BR112022008294A2 (pt) Composições de profármaco e métodos de tratamento
CL2018003431A1 (es) Tratamiento de la enfermedad de parkinson.
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
BR112017022158A2 (pt) compostos, composições farmacêuticas e uso de um composto
AR094707A1 (es) Compuesto de quinazolin-4-amina, composición farmacéutica que lo comprende y su uso para el tratamiento de una enfermedad mediada por la quinasa rip2
PE20161385A1 (es) Formulacion inmunosupresora
SV2018005702A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
CL2019001618A1 (es) Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar.
CL2019001623A1 (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor.
MX2021001612A (es) Compuestos utiles en terapia del vih.